Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 17
--> 1— Introduction and Background The U.S. Army's Chemical Defense Equipment Process Action Team (CDEPAT) recently conducted an extensive review of the scientific basis for toxicity estimates in use by the Army for several chemical-warfare (CW) agents: GA, GB, GD, GF, VX, and HD. Following a detailed analysis of the toxicity of these agents and using contemporary methods of analysis, CDEPAT concluded that many of the human-toxicity estimates in use would not protect the soldier adequately (CDEPAT 1994). Recalculations of the potencies of several of the CW agents indicate that their potencies are greater than previously determined. As a result, lower exposure levels of CW agents are expected to elicit adverse effects. Before deciding whether to implement CDEPAT's recommendations, the U.S. Department of the Army requested that the National Research Council (NRC) independently review the CDEPAT report entitled Review of Existing Toxicity Data and Human Estimates for Selected Chemical Agents and Recommended Human Toxicity Estimates for Defending the Soldier. The NRC assigned the project to the Committee on Toxicology (COT) of the Board on Environmental Studies and Toxicology. The COT convened the Subcommittee on Toxicity Values for Selected Nerve and Vesicant Agents, which conducted the study and prepared this report. Subcommittee members were chosen for their expertise in several specialties, including
OCR for page 18
--> toxicology, medicine, pathology, biostatistics, and risk assessment. The subcommittee was charged with determining the scientific validity of CDEPAT's proposed human-toxicity estimates for CW agents for various routes of exposure (that is, percutaneous vapor exposures, vapor inhalation exposures, and percutaneous liquid exposures). The report considers only acute1 exposures and acute effects. It should be noted that the human-toxicity estimates for the CW agents were proposed for healthy adult male soldiers only. They must not be used for the general population. Specifically, the subcommittee was charged with the following tasks: Review the scientific protocols and the quality of the toxicity data used in revising the human-toxicity estimates for acute exposures. Review the toxicity estimates for mild and nonsevere effects and for severe and lethal effects. Review the procedures used in deriving the human-toxicity estimates for acute exposures. Determine the appropriateness of the assumptions made in deriving the human-toxicity estimates for acute exposures. In reviewing the toxicity data and the proposed human-toxicity estimates for acute exposures, the subcommittee evaluated the quality of the data, the appropriateness of the procedures used in obtaining the estimates, and the assumptions made in deriving them. The subcommittee also determined whether the supporting documentation justified the proposed recommendations and whether the studies and toxicity end points were appropriate for deriving the toxicity estimates. In reviewing the proposed human-toxicity estimates, the subcommittee reviewed only the toxicity information presented in the CDEPAT report. It did not perform an independent literature search, nor did it review any data other than those presented in the report. In addition, the subcommittee was not asked to recommend new estimates or to address the policy or operational consequences of the proposed lower human-toxicity estimates. The exposures used in the estimates are defined as follows: LCt50 is the exposure to a vapor causing lethality in 50% of a given population and is expressed as the product of air concentration (c), in 1 A one-time, short-term exposure; for example, < 1 hr.
OCR for page 19
--> milligrams per cubic meter, and exposure duration (t), usually in minutes.2 Ct refers to the product of concentration and exposure time. LCt50s were derived for either inhalation or percutaneous vapor exposures. It is important to note that the product of concentration and exposure duration (c × t) is not necessarily a constant. ECt50 is the exposure to a vapor causing a defined effect in 50% of a given population and is expressed as the product of c × t in mg-min/m3, where c × t is not necessarily a constant. The effects include those classified as threshold (minimal), mild (miosis and/or rhinorrhea), or severe (incapacitation, prostration, collapse, and convulsions). ECt50s were derived for either inhalation or percutaneous vapor exposures. ICt50 is the exposure to a vapor causing incapacitation in 50% of a given population and is expressed as the product of c × t in mg-min/m3, where c × t is not necessarily a constant. LD50 is the acute dose of a liquid agent causing lethality in 50% of a given population and is expressed in milligrams per kilogram of body weight (mg/kg). In this report, all LD50s are for percutaneous liquid exposure of bare skin. ID50 is the acute dose of a liquid agent causing incapacitation in 50% of a given population and is expressed in mg/kg. In this report, all ID50s are for percutaneous liquid exposure of bare skin. ED50 is the acute dose of a liquid agent causing a defined effect in 50% of a given population and is expressed in mg/kg. In this report, all ED50s are for percutaneous liquid exposure of bare skin. Effects include those in the threshold, mild, or severe (including incapacitation) categories. The results of the subcommittee's deliberations are presented in Chapters 2 through 8 of this report. Chapters 2 through 7 review CDEPAT's proposed human-toxicity estimates for agents GA, GB, GD, GF, VX, and HD, respectively. Those chapters provide conclusions on the scientific validity of the proposed acute human-toxicity estimates and recommendations for research efforts. Chapter 8 evaluates the risk-estimation procedures used in the CDEPAT report. The Appendix discusses the offensive versus the defensive use of human-toxicity estimates for CW agents. 2 The LCt50 units are abbreviated mg-min/m3.
Representative terms from entire chapter: